ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,250, issued on Dec. 9, was assigned to Emory University (Atlanta) and Rush University Medical Center (Chicago).

"suPAR and prediction and treatment of acute kidney injury" was invented by Jochen Reiser (Chicago), Salim Hayek (Ann Arbor, Mich.) and Arshed A. Quyyumi (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for treating acute kidney injury in a subject are provided. The methods include measuring or having measured a level of soluble urokinase plasminogen activator receptor (suPAR) in a biological sample from the subject, determining or having determined the level of suPAR in the sample compared to a control suPAR...